Filed pursuant to Rule 424(b)(3)
File No. 333-272286
PROSPECTUS SUPPLEMENT
(To Prospectus dated October 5, 2023, as
supplemented by the Prospectus
Supplement dated
November 15, 2023, the Prospectus Supplement dated
January 30, 2024 and the Prospectus Supplement
dated May 21, 2024) |
|
July 29, 2024 |
Oxford Lane Capital Corp.
$750,000,000
Common Stock
This prospectus supplement
contains information which amends, supplements and modifies certain information contained in the prospectus dated October 5, 2023 (the
“Base Prospectus”) as supplemented by the prospectus supplement dated November 15, 2023 (the “November 2023 Prospectus
Supplement”), the prospectus supplement dated January 30, 2024 (the “January 2024 Prospectus Supplement”) and the prospectus
supplement dated May 21, 2024 (the “May 2024 Prospectus Supplement” and, together with the November 2023 Prospectus Supplement
and the January 2024 Prospectus Supplement, the “Prior Prospectus Supplements”, and together with this prospectus supplement
and the Base Prospectus, the “Prospectus”), which relate to the sale of shares of common stock of Oxford Lane Capital Corp.
(the “Company”) in an “at-the-market” offering pursuant to an Amended and Restated Equity Distribution Agreement
dated September 9, 2022, as amended pursuant to that certain Amendment No. 1, dated as of November 15, 2023, and that certain Amendment
No. 2, dated as of July 29, 2024 (collectively, the “Amended Equity Distribution Agreement”), with Ladenburg Thalmann &
Co. Inc. and Lucid Capital Markets, LLC (the “Distribution Agents”). The Company’s investment adviser, Oxford Lane Management,
LLC (the “Adviser”), has agreed to pay to the Distribution Agents, if necessary, a supplemental payment per share that will
reflect the difference between the public offering price per share and the net proceeds per share received by the Company in this offering
such that the net proceeds per share received by the Company (before expenses) are not below the Company’s then current net asset
value per share.
This prospectus supplement
supersedes the Prior Prospectus Supplements to the extent it contains information that is different from or in addition to the information
in the Prior Prospectus Supplements. Unless otherwise indicated, all other information included in the Prior Prospectus Supplements that
is not inconsistent with the information set forth in this prospectus supplement remains unchanged.
You should carefully read the
entire Prospectus before investing in our common stock. You should also review the information set forth under the “Risk Factors”
section beginning on page 15 of the Base Prospectus and in our subsequent filings with the Securities and Exchange Commission (the “SEC”)
that are incorporated by reference into the Prospectus, before investing.
The terms “Oxford Lane,”
the “Company,” “we,” “us” and “our” generally refer to Oxford Lane Capital Corp.
PRIOR SALES PURSUANT TO THE “AT THE MARKET”
OFFERING
From November 15, 2023 to July
26, 2024, we sold a total of 82,574,949 shares of common stock pursuant to the “at-the-market” offering. The total amount
of capital raised as a result of these sales of common stock was approximately $430.3 million and net proceeds were approximately $427.4
million, after deducting the sales agent’s commissions and offering expenses.
FIRST QUARTER FINANCIAL HIGHLIGHTS
| ● | On July 25, 2024, our Board of Directors declared the following distributions on our common stock: |
Month Ending | |
Record Date | |
Payment Date | |
Amount Per Share |
October 31, 2024 | |
October 17, 2024 | |
October 31, 2024 | |
$0.09 |
November 30, 2024 | |
November 15, 2024 | |
November 29, 2024 | |
$0.09 |
December 31, 2024 | |
December 17, 2024 | |
December 31, 2024 | |
$0.09 |
| ● | Net asset value (“NAV”) per share as of June 30, 2024 stood at $4.91, compared with a NAV
per share on March 31, 2024 of $4.90. |
| ● | Net investment income (“NII”), calculated in accordance with U.S. generally accepted accounting
principles (“GAAP”), was approximately $56.0 million, or $0.22 per share, for the quarter ended June 30, 2024. |
| ● | Our core net investment income (“Core NII”) was approximately $107.2 million, or $0.41 per
share, for the quarter ended June 30, 2024. |
| o | Core NII incorporates all applicable cash distributions received, or entitled to be received (if any,
in either case), on our collateralized loan obligation (“CLO”) equity investments. See additional information under “Supplemental
Information Regarding Core Net Investment Income” below. |
| o | We emphasize that our taxable income may differ materially from our GAAP NII and/or our Core NII, and
that neither GAAP NII nor Core NII should be relied upon as indicators of our taxable income. |
| ● | Total investment income for the quarter ended June 30, 2024 amounted to approximately $89.8 million, which
represented an increase of approximately $7.1 million from the quarter ended March 31, 2024. |
| o | For the quarter ended June 30, 2024 we recorded investment income as follows: |
| ◾ | Approximately $84.0 million from our CLO equity and CLO warehouse investments, and |
| ◾ | Approximately $5.7 million from our CLO debt investments and other income. |
| ● | Our total expenses for the quarter ended June 30, 2024 were approximately $33.8 million, compared with
total expenses of approximately $31.7 million for the quarter ended March 31, 2024. |
| ● | As of June 30, 2024, the following metrics applied (note that none of these metrics represented a total
return to shareholders): |
| o | The weighted average yield of our CLO debt investments at current cost was 17.4%, up from 17.1% as of
March 31, 2024. |
| o | The weighted average effective yield of our CLO equity investments at current cost was 16.8%, down from
16.9% as of March 31, 2024. |
| o | The
weighted average cash distribution yield of our CLO equity investments at current cost was 26.9%, up from 23.5% as of March 31, 2024. |
| ● | For the quarter ended June 30, 2024, we recorded a net increase in net assets resulting from operations
of approximately $47.7 million, or $0.18 per share, comprised of: |
| o | NII of approximately $56.0 million; |
| o | Net realized gains of approximately $6.1 million; and |
| o | Net unrealized depreciation of approximately $14.4 million. |
| ● | During the quarter ended June 30, 2024, we made additional investments of approximately $216.9 million,
and received approximately $96.3 million from sales and repayments of our CLO investments. |
| ● | For the quarter ended June 30, 2024, we issued a total of approximately 45.9 million shares of common
stock pursuant to an “at-the-market” offering. After deducting the sales agent’s commissions and offering expenses,
this resulted in net proceeds of approximately $242.1 million. As of June 30, 2024, we had approximately 287.0 million shares of common
stock outstanding. |
| ● | On July 25, 2024, our Board of Directors declared the required monthly dividends on our 6.25% Series 2027
Term Preferred Shares, 6.00% Series 2029 Term Preferred Shares, and 7.125% Series 2029 Term Preferred Shares as follows: |
Preferred Shares Type | |
Per Share
Dividend
Amount
Declared | | |
Record Dates | |
Payment Dates |
6.25% - Series 2027 | |
$ | 0.13020833 | | |
September 16, 2024, October 17, 2024, November 15, 2024 | |
September 30, 2024, October 31, 2024, November 29, 2024 |
6.00% - Series 2029 | |
$ | 0.12500000 | | |
September 16, 2024, October 17, 2024, November 15, 2024 | |
September 30, 2024, October 31, 2024, November 29, 2024 |
7.125% - Series 2029 | |
$ | 0.14843750 | | |
September 16, 2024, October 17, 2024, November 15, 2024 | |
September 30, 2024, October 31, 2024, November 29, 2024 |
In accordance with their terms, each of the 6.25%
Series 2027 Term Preferred Shares, 6.00% Series 2029 Term Preferred Shares, and 7.125% Series 2029 Term Preferred Shares will pay a monthly
dividend at a fixed rate of 6.25%, 6.00% and 7.125%, respectively, of the $25.00 per share liquidation preference, or $1.5625, $1.5000
and $1.78125 per share per year, respectively. This fixed annual dividend rate is subject to adjustment under certain circumstances, but
will not, in any case, be lower than 6.25%, 6.00% and 7.125% per year, respectively, for each of the 6.25% Series 2027 Term Preferred
Shares, 6.00% Series 2029 Term Preferred Shares and 7.125% Series 2029 Term Preferred Shares.
Supplemental Information Regarding Core Net
Investment Income
We provide information relating to Core NII (a
non-GAAP measure) on a supplemental basis. This measure is not provided as a substitute for GAAP NII, but in addition to it. Our non-GAAP
measures may differ from similar measures by other companies, even in the event of similar terms being utilized to identify such measures.
Core NII represents GAAP NII adjusted for additional applicable cash distributions received, or entitled to be received (if any, in either
case), on our CLO equity investments. Oxford Lane’s management uses this information in its internal analysis of results and believes
that this information may be informative in assessing the quality of Oxford Lane’s financial performance, identifying trends in
its results and providing meaningful period-to-period comparisons.
Income from investments in the “equity”
class securities of CLO vehicles, for GAAP purposes, is recorded using the effective interest method; this is based on an effective yield
to the expected redemption utilizing estimated cash flows, at current cost, including those CLO equity investments that have not made
their inaugural distribution for the relevant period end. The result is an effective yield for the investment in which the respective
investment’s cost basis is adjusted quarterly based on the difference between the actual cash received, or distributions entitled
to be received, and the effective yield calculation. Accordingly, investment income recognized on CLO equity securities in the GAAP statement
of operations differs from the cash distributions actually received by the Company during the period (referred to below as “CLO
equity adjustments”).
Furthermore, in order for the Company to continue
qualifying as a regulated investment company for tax purposes, we are required, among other things, to distribute at least 90% of our
investment company taxable income annually. While Core NII may provide a better indication of our estimated taxable income than GAAP NII
during certain periods, we can offer no assurance that will be the case, however, as the ultimate tax character of our earnings cannot
be determined until after tax returns are prepared at the close of a fiscal year. We note that this non-GAAP measure may not serve as
a useful indicator of taxable earnings, particularly during periods of market disruption and volatility, and, as such, our taxable income
may differ materially from our Core NII.
The following table provides a reconciliation
of GAAP NII to Core NII for the three months ended June 30, 2024:
| |
Three Months Ended | |
| |
June 30, 2024 | |
| |
| | |
Per Share | |
| |
Amount | | |
Amount | |
GAAP net investment income | |
$ | 55,954,863 | | |
$ | 0.22 | |
CLO equity adjustments | |
| 51,279,902 | | |
| 0.19 | |
Core net investment income | |
$ | 107,234,765 | | |
$ | 0.41 | |
UPDATE TO “AT-THE-MARKET” OFFERING
On July 29, 2024, the Company
and Distribution Agents entered into that certain Amendment No. 2 to the Amended and Restated Equity Distribution Agreement dated September
9, 2022 which adds Lucid Capital Markets, LLC as a Distribution Agent thereunder.
All references to Ladenburg
Thalmann & Co. Inc. in the Prior Prospectus Supplements shall be deemed to refer to Ladenburg Thalmann & Co. Inc. and Lucid Capital
Markets, LLC together as Distributions Agents, unless otherwise stated in this prospectus supplement or unless context requires otherwise.
PLAN OF DISTRIBUTION
The Distribution Agents are
acting as our sales agents in connection with the offer and sale of shares of our common stock pursuant to the Prospectus. Upon written
instructions from us, the Distribution Agents will use their commercially reasonable efforts consistent with their normal trading and
sales practices to sell, as our sales agents, our common stock under the terms and subject to the conditions set forth in our Amended
Equity Distribution Agreement.
We will instruct one or both
Distribution Agents as to the amount of common stock to be sold by them. We may instruct the Distribution Agents not to sell common stock
if the sales cannot be effected at or above the price designated by us in any instruction. The sales price per share of our common stock
offered by the Prospectus, less the Distribution Agents’ commissions, will not be less than the net asset value per share of our
common stock at the time of such sale. We or the Distribution Agents may suspend the offering of shares of common stock upon proper notice
and subject to other conditions.
Sales of our common stock,
if any, under the Prospectus may be made in privately negotiated transactions or transactions that are deemed to be “at the market,”
as defined in Rule 415 under the Securities Act, including sales made directly on the NASDAQ Global Select Market or similar securities
exchange or sales made to or through a market maker other than on an exchange at prices related to the prevailing market prices or at
negotiated prices.
The Distribution Agents will
provide written confirmation of a sale to us no later than the opening of the trading day on the NASDAQ Global Select Market following
each trading day in which shares of our common stock are sold under the Amended Equity Distribution Agreement. Each confirmation will
include the number of shares of common stock sold on the preceding day, the net proceeds to us and the compensation payable by us to the
Distribution Agents in connection with the sales.
The Distribution Agents will
receive a commission from us equal to the lesser of (i) 2.0% of the gross sales price per share from such sale or (ii) the difference
between the gross sale price per share from such sale and the amount the Company, in its sole discretion, determines to be its minimum
net amount, with respect to any shares of our common stock sold through the Distribution Agents under the Amended Equity Distribution
Agreement. Oxford Lane Management has agreed to pay to the Distribution Agents, if necessary, a supplemental payment per share that will
reflect the difference between the public offering price per share and the net proceeds per share received by us in this offering such
that the net proceeds per share received by us (before expenses) are not below our then current net asset value per share. We estimate
that the total expenses for the offering, excluding compensation payable to the Distribution Agents under the terms of the Amended Equity
Distribution Agreement, will be approximately $337,500.
Settlement for sales of shares
of common stock will occur on the trading day following the date on which such sales are made, or on some other date that is agreed upon
by us and the Distribution Agents in connection with a particular transaction, in return for payment of the net proceeds to us. There
is no arrangement for funds to be received in an escrow, trust or similar arrangement.
We will report at least quarterly
the number of shares of our common stock sold through the Distribution Agents under the Amended Equity Distribution Agreement and the
net proceeds to us.
In connection with the sale
of the common stock on our behalf, the Distribution Agents may each be deemed to be an “underwriter” within the meaning of
the Securities Act, and the compensation of the Distribution Agents may be deemed to be underwriting commissions or discounts. We have
agreed to provide indemnification and contribution to the Distribution Agents against certain civil liabilities, including liabilities
under the Securities Act.
The offering of our shares
of common stock pursuant to the Amended Equity Distribution Agreement will terminate upon the earlier of (i) the sale of the dollar amount
of common stock subject to the Amended Equity Distribution Agreement or (ii) the termination of the Amended Equity Distribution Agreement.
The Amended Equity Distribution Agreement may be terminated by us in our sole discretion with respect to one or both Distribution Agents
under the circumstances specified in the Amended Equity Distribution Agreement by giving notice to the applicable Distribution Agent.
In addition, either Distribution Agent may terminate its participation in the Amended Equity Distribution Agreement under the circumstances
specified in the Amended Equity Distribution Agreement by giving notice to us.
Potential Conflicts of Interest
The
Distribution Agents and their affiliates are full service financial institutions engaged in various activities, which may include securities
trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging,
financing and brokerage activities. The Distribution Agents and their affiliates have, from time to time, performed, and may in the future
perform, various financial advisory and investment banking services for us, for which they received or will receive customary fees and
reimbursement of expenses, including acting as underwriters for our securities offerings. In the ordinary course of their various business
activities, the Distribution Agents and their affiliates may make or hold a broad array of investments and actively trade debt and equity
securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts
of their customers and such investment and securities activities may involve securities and/or instruments of our company. The Distribution
Agents and their affiliates may also make investment recommendations and/or publish or express independent research views in respect of
such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such
securities and instruments.
The principal business address
of Ladenburg Thalmann & Co. Inc. is 640 Fifth Avenue, 4th Floor, New York, New York 10019 and the principal business address of Lucid
Capital Markets, LLC is 570 Lexington Avenue, 40th Floor, New York, NY 10022.
424B3
false
0001495222
0001495222
2024-07-29
2024-07-29
0001495222
2024-06-30
2024-06-30
0001495222
2024-03-31
2024-03-31
xbrli:shares
iso4217:USD
xbrli:shares